Post-approval studies (Phase 4)Looking for participantsNCT07160231
What this trial is testing
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Who this might be right for
Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Axial Spondyloarthritis (AxSpA)
Sint Maartenskliniek 200